You are here: Industry Insights > Recipharm

News List

Recipharm’s Erdosteine to be Tested for COVID-19 Treatment contractpharma
April 09, 2020
Trial in Italy evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2.
Recipharm Sees Increased Demand for Chloroquine Phosphate contractpharma
March 09, 2020
Interest is due to chloroquine's antiviral effects, which has potential use in treating coronavirus.
Recipharm extends the acceptance period for the offer to acquire Consort Medical and updates on level of acceptance firstwordpharma
January 11, 2020
Consort Shareholders who have not yet accepted the Offer and who wish to do so should take action to accept the Offer as soon as possible. Details of the procedure for doing so are set out in the Offer Document.
Recipharm Invests in Inhalation Development Services contractpharma
December 12, 2019
Recipharm has invested $450,000 into its Research Triangle Park (RTP), NC facility to install a SprayVIEW system that will support inhalation and nasal product development.
Recipharm Launches Inhalation Offering contractpharma
May 16, 2019
Offers fully integrated service from early stage development through to commercial manufacturing for MDIs, DPIs, and nasal sprays.
140 jobs in jeopardy as Recipharm weighs the fate of money-losing plant fiercepharma
December 20, 2018
A Recipharm plant in the U.K. has been on the edge financially for some time, having been unprofitable for three years. Now, the Swedish-based CDMO says the cost of fixing issues raised by U.K. authorities may be the breaking point.
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment pharmatimes
November 27, 2018
Recipharm's proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as one of the commonly
Recipharm to Continue Mfg. Ops in Höganäs, Sweden contractpharma
October 22, 2018
Reverses previous decision to discontinue ops due to demand
Recipharm connects to European Hub for serialisation compliance cphi-online
September 20, 2018
Connection allows the marketing authorisation holders within the Recipharm Group to continue to supply medicines to patients post the EU FMD implementation date.
Recipharm Launches Standalone Serialization Service contractpharma
July 03, 2018
Recipharm has announced the launch of its standalone serialization service ahead of the introduction of the EU Falsified Medicines Directive (FMD).

Previous page 1 2 3 4 5 Next page